Gene · 1308
Papers3,031
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 3,031
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| COVID-19 Vaccine: A Potential Risk Factor for Accelerating the Onset of Bullous Pemphigoid. | Vaccines (Basel) | 2024 | 39340046 | PubTator, text mining | PubMed |
| The possible and intriguing relationship between bullous pemphigoid and melanoma: speculations on significance and clinical relevance. | Front Immunol | 2024 | 39267741 | PubTator, text mining | PubMed |
| The Role of Serology in the Diagnosis of Ocular Predominant Mucous Membrane Pemphigoid and the Search for an Ocular-Specific Autoantigen. | Ocul Immunol Inflamm | 2024 | 39241171 | PubTator, text mining | PubMed |
| Isolation and analysis of the exosomal membrane proteins in bullous pemphigoid. | Expert Rev Clin Immunol | 2024 | 39230197 | PubTator, text mining | PubMed |
| Autoantigen-specific CD4+ T cells acquire an exhausted phenotype and persist in human antigen-specific autoimmune diseases. | Immunity | 2024 | 39226901 | PubTator, text mining | PubMed |
| Heterozygous COL17A1 variants are a frequent cause of amelogenesis imperfecta. | J Med Genet | 2024 | 39214682 | PubTator, text mining | PubMed |
| The Deubiquitinase USP22-Stabilized COL17A1 Promotes Lung Adenocarcinoma Progression. | Clin Respir J | 2024 | 39143031 | PubTator, text mining | PubMed |
| A 3-year-old child with multiple superficial erosions and yellowish crusts on the scalp and seborrheic areas. | JAAD Case Rep | 2024 | 39100801 | PubTator, text mining | PubMed |
| Single-cell transcriptomics analysis of bullous pemphigoid unveils immune-stromal crosstalk in type 2 inflammatory disease. | Nat Commun | 2024 | 39009587 | PubTator, text mining | PubMed |
| Prevalence and characterization of an integrative and conjugative element carrying tet(X) gene in Elizabethkingia meningoseptica. | J Glob Antimicrob Resist | 2024 | 39004340 | PubTator, text mining | PubMed |
| [Clinical and bioinformatics analysis of the relationship between LAMA3 DNA methylation expression and platinum resistance and prognosis in epithelial ovarian cancer]. | Zhonghua Fu Chan Ke Za Zhi | 2024 | 38951081 | PubTator, text mining | PubMed |
| Reactivity against the BP180 ectodomain in patients with bullous pemphigoid, mucous membrane pemphigoid, multiple sclerosis and Parkinson disease. | Exp Dermatol | 2024 | 38946225 | PubTator, text mining | PubMed |
| A New Age of Biocatalysis Enabled by Generic Activation Modes. | JACS Au | 2024 | 38938808 | PubTator, text mining | PubMed |
| Development of bullous pemphigoid with autoantibodies against full-length BP180 following COVID-19 infection. | J Dermatol | 2024 | 38924110 | PubTator, text mining | PubMed |
| Pemphigus vegetans with autoantibodies against desmocollin and BP180. | Eur J Dermatol | 2024 | 38907556 | PubTator, text mining | PubMed |
| State-of-the-art diagnosis of autoimmune blistering diseases. | Front Immunol | 2024 | 38903493 | PubTator, text mining | PubMed |
| Interest of therapeutic plasmapheresis in a chronic hemodialysis patient with severe bullous pemphigoid. | J Clin Apher | 2024 | 38881050 | PubTator, text mining | PubMed |
| [A case of Neonatal generalized atrophic benign epidermolysis bullosa due to variants of COL17A1 gene]. | Zhonghua Yi Xue Yi Chuan Xue Za Zhi | 2024 | 38818561 | PubTator, text mining | PubMed |
| Occurrence of Bullous Pemphigoid in a Longstanding Case of Rheumatoid Arthritis in an Indian Patient: A Rare Association. | Cureus | 2024 | 38807846 | PubTator, text mining | PubMed |
| Absence of Epidermal Antibodies in Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis Patients but Beware of Single Positive Results. | Dermatol Res Pract | 2024 | 38803350 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1308/papers?page=12